Short Term Rating on St. Jude Medical (STJ)

St. Jude Medical (STJ) : The consensus on St. Jude Medical (STJ) based on 21 analyst recommendation on the company stock is 2.81, which is interpreted as a Hold recommendation. Zacks Investment Research has issued a rank of 2 which endorses a Buy on the stock. However, 2 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 19 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating.

St. Jude Medical (STJ) : 18 investment research analysts covering St. Jude Medical (STJ) have an average price target of $73.81 for the near short term. The highest target price given by the Brokerage Firm to the stock is $91 and the lowest target is $54 for the short term. Analysts expect the variance to be within $11.55 of the average price.

Company shares have received an average consensus rating of Hold for the current week


St. Jude Medical (NYSE:STJ): During Tuesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $80.75 and $80.68 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $81.21. The buying momentum continued till the end and the stock did not give up its gains. It closed at $80.88, notching a gain of 0.26% for the day. The total traded volume was 2,007,320 . The stock had closed at $80.67 on the previous day.

St. Jude Medical, Inc. develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. Its six principal product categories include tachycardia implantable cardioverter defibrillator (ICD) systems, bradycardia pacemaker systems, atrial fibrillation (AF) products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems), vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, heart failure monitoring device and other vascular accessories), structural heart products and neuromodulation products (spinal cord stimulation and radiofrequency ablation to treat chronic pain and deep brain stimulation to treat movement disorders).

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.